chrisdh79 OP t1_it6ryt8 wrote
From the article: Engineers at Duke University have developed a novel delivery system for cancer treatment and demonstrated its potential against one of the disease’s most troublesome forms. In newly published research in mice with pancreatic cancer, the scientists showed how a radioactive implant could completely eliminate tumors in the majority of the rodents, demonstrating what they say is the most effective treatment ever studied in these pre-clinical models.
Pancreatic cancer is notoriously difficult to diagnose and treat, with tumor cells of this type highly evasive and loaded with mutations that make them resistant to many drugs. It accounts for just 3.2 percent of all cancers, yet is the third leading cause of cancer-related death. One way of tackling it is by deploying chemotherapy to hold the tumor cells in a state that makes them vulnerable to radiation, and then hitting the tumor with a targeted radiation beam.
But doing so in a way that attacks the tumor but doesn’t expose the patient to heavy doses of radiation is a fine line to tread, and raises the risk of severe side effects. Another method scientists are exploring is the use of implants that can be placed directly inside the tumor to attack it with radioactive materials from within. They have made some inroads using titanium shells to encase the radioactive samples, but these can cause damage to the surrounding tissue.
"There's just no good way to treat pancreatic cancer right now," said study author Jeff Schaal.
illPMyoumycatanddog t1_it7e0a3 wrote
This just sounds like an improved way to do brachytherapy rather than a "novel delivery system for cancer treatment".
R1ckMartel t1_it7rs6o wrote
Yeah, there is nothing novel about this.
Silpion t1_it84ql5 wrote
Injecting the source as a liquid solution that hardens inside the body isn't novel?
R1ckMartel t1_it85txq wrote
There are numerous targeted molecular therapies with radiopharmaceuticals that would achieve precise localization to the tumor when attached to a ligand and chelating molecule. Hardening is irrelevant.
Lutathera is a prime example.
Why they choose I-131 is bizarre to me. It has a more mixed emission spectrum (a 364 kEV gamma) that would irradiate more of the surrounding, healthy tissue than other agents like Lutetium-177 that are almost pure beta-emitters.
dern_the_hermit t1_it94p5n wrote
> Hardening is irrelevant.
"If you ignore the thing that's novel, why, there's nothing novel about this!"
R1ckMartel t1_it9ke3w wrote
They're called polaxamers and are not novel:
[deleted] t1_it7bv3o wrote
[removed]
Viewing a single comment thread. View all comments